IRIS
BOCCARELLI, Angelina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.451
EU - Europa 817
AS - Asia 361
OC - Oceania 4
SA - Sud America 1
Totale 4.634
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.446
CN - Cina 327
SE - Svezia 282
IT - Italia 156
UA - Ucraina 108
DE - Germania 95
FI - Finlandia 83
GB - Regno Unito 37
IN - India 19
BE - Belgio 15
FR - Francia 14
IE - Irlanda 13
RU - Federazione Russa 9
CA - Canada 5
IR - Iran 5
AU - Australia 4
VN - Vietnam 4
KR - Corea 2
BG - Bulgaria 1
BN - Brunei Darussalam 1
CH - Svizzera 1
CL - Cile 1
EE - Estonia 1
RO - Romania 1
SA - Arabia Saudita 1
SG - Singapore 1
SI - Slovenia 1
TR - Turchia 1
Totale 4.634
Salva come PNG Salva come JPEG
Città #
Fairfield 400
Woodbridge 374
Chandler 370
Jacksonville 262
Nyköping 242
Ashburn 239
Houston 209
Seattle 190
Cambridge 171
Ann Arbor 164
Wilmington 156
Bari 101
Nanjing 101
Lawrence 88
Roxbury 88
New York 78
Beijing 69
Des Moines 60
Princeton 38
Inglewood 31
Boardman 27
Helsinki 27
Hebei 26
Dearborn 25
Nanchang 25
Shenyang 24
San Diego 22
Brooklyn 18
Jiaxing 16
Pune 16
Brussels 15
Tianjin 15
Dublin 12
Milan 9
Changsha 7
Kunming 7
Ningbo 7
Paris 7
Los Angeles 6
San Francisco 6
Washington 6
Ardabil 5
Hefei 5
Dong Ket 4
Leawood 4
Redwood City 4
Toronto 4
Auburn Hills 3
Jinan 3
Lanzhou 3
London 3
Marseille 3
San Mateo 3
Terlizzi 3
Zhengzhou 3
Augusta 2
Baotou 2
Berlin 2
Edinburgh 2
Grafing 2
Guangzhou 2
Kilburn 2
Melbourne 2
Monmouth Junction 2
Mumbai 2
Taizhou 2
Bandar Seri Begawan 1
Brisbane 1
Chicago 1
Chiswick 1
Falls Church 1
Frankfurt am Main 1
Fuzhou 1
Harbin 1
Hounslow 1
Indiana 1
La Canada Flintridge 1
Ljubljana 1
Markham 1
Modugno 1
Nantong 1
New Orleans 1
Norwalk 1
Qingdao 1
Riyadh 1
Rome 1
Saratov 1
Shaoxing 1
Simi Valley 1
Sofia 1
Stockholm 1
Suceava 1
Sydney 1
Tallinn 1
Tappahannock 1
Trani 1
West Jordan 1
Wexford 1
Zurich 1
Totale 3.859
Salva come PNG Salva come JPEG
Nome #
The Challenge of Establishing Reliable Screening Tests for Selecting Anticancer Metal Compounds 135
A new class of 1-aryl-5,6-dihydropyrrolo[2,1-a]isoquinoline derivatives as reversers of P-glycoprotein-mediated multidrug resistance in tumor cells 125
Investigating Structural Requirements for the Antiproliferative Activity of Biphenyl Nicotinamides 125
Translational impact of novel widely pharmacological characterized mofezolac-derived COX-1 inhibitors combined with bortezomib on human multiple myeloma cell lines viability 122
Effect of mofezolac-galactose distance in conjugates targeting cyclooxygenase (COX)-1 and CNS GLUT-1 carrier 116
Effect of cisplatin containing liposomes formulated by unsaturated chain-containing lipids on gynecological tumor cells. 113
null 104
Improving knowledge on the activation of bone marrow fibroblasts in MGUS and MM disease through the automatic extraction of genes via a nonnegative matrix factorization approach on gene expression profiles. 103
Novel Antiproliferative Biphenyl Nicotinamide: NMR Metabolomic Study of its Effect on the MCF-7 Cell in Comparison with Cisplatin and Vinblastine 99
Novel targeting of phospho-cMET overcomes drug resistance and induces antitumor activity in multiple myeloma 95
null 90
null 88
Antimetastatic properties and DNA interactions of the novel class of dimeric Ru(III) compounds [Na]2{trans-RuCl4(Me2SO)]2(µ-L)} (L = ditopic, non-chelating aromatic N-ligand) 86
DNA binding specificity of the antitumor complexes cis- and trans-RuCl2(DMSO)4 determined by primer extension footprinting assay 82
Platinum(II) based anticancer agents with a trans geometry 78
Endothelial cells in the bone marrow of patients with multiple myeloma 77
Sterically hindered complexes of platinum(II) with planar heterocyclic nitrogen donors. A novel complex with 1-methyl-cytosine has a spectrum of activity different from cisplatin and is able of overcoming acquired cisplatin resistance 76
Synthesis and in vitro antitumor activity of platinum acetonimine complexes 74
Processo di sintesi di complessi di platino con imminoeteri e loro utilizzazione come agenti antitumorali e agenti modificanti le basi nucleotidiche 69
null 68
null 67
Antitumour platinum iminoether complexes 66
null 66
null 65
Platinum(II)-Acyclovir complexes of acyclovir: synthesis, antiviral and antitumor activity 65
null 65
Antitumour platinum-iminoether complexes 64
Pharmacological action of the platinum-iminoether complex cis-[PtCl2{E-HN=C(OMe)}NH3] 63
Iminoethers as Carrier Ligands: A Novel trans-Platinum Complex Possessing in Vitro and in Vivo Antitumour Activity 59
Bone marrow fibroblasts provide a permissive microenvironement for multiple myeloma cells 58
Antitumour platinum iminoether complexes 58
Bone marrow fibroblasts provide a permissive microenvironment for multiple myeloma cells. 56
Anti-leukaemic action of RuCl2 (DMSO)4 isomers and prevention of brain involvement on P388 leukaemia and on P388/DDP subline 56
Antitumour activity and matrix metalloproteinase inhibition by platinum-diethyl{(methylsulfinyl)methyl}phosphonate complexes 55
Leading-edge gold(III) derivatives in targeted anticancer therapy: in vivo acute toxicity investigation and transcriptomic analysis of treatment-induced response in two human breast cancer cell lines. 55
null 55
null 55
Antitumour ruthenium(II)-dimethylsulfoxide complexes 53
null 53
Inhibition of matrix metallo proteinases activity by platinum complexes 52
Antitumor activity of trans platinum complexes 52
null 52
null 51
Platinum complexes with bisphosphonate analogue: a novel dual mechanism of antitumour action 49
Bone Marrow Fibroblasts and Multiple Myeloma Progression 49
Water soluble ruthenium(III)-dimethylsulfoxide complexes: chemical behavior and pharmacological properties 48
Inibizione di metalloproteasi da parte di complessi di platino con analoghi bisfosfonati 48
Cytotoxicity of some platinum(IV) complexes with ethylenediamine-N,N'-di-3-prppionato ligands 46
An NMF-Based Methodology for Selecting Biomarkers in the Landscape of Genes of Heterogeneous Cancer-Associated Fibroblast Populations 46
Reductive Domino Reaction to Access Chromeno [2, 3-c] isoquinoline-5-amines with Antiproliferative Activities Against Human Tumor Cells 46
Identification of genes associated with platinum iminoether compounds activity in ovarian cancer cells 44
Genomic analysis of the differential processing of antitumor-active and antitumor-inactive trans platinum compuonds 43
MMP activity inhibition by platinum-diethyl[(methylsulfinyl)methyl]phosphonate (SMP) complexes” 42
Analisi dell’espressione genica (Dna Microarray) in cellule endoteliali e cellule tumorali dopo trattamento con il farmaco antimetastatico sperimentale Nami-A 41
Inhibition of endothelial cell function and angiogenesis by the metastasis inhibitor NAMI-A 41
Effects of trans-[PtCl2(NH3){Z-HN=C(OMe)Me}] (trans-Z) and Transplatin on cell-cycle progression and gene expression of SVOK-3 ovarian cancer cells 40
Cellular and biochemical properties of antitumour trans platinum-iminoether complexes 40
Comparison of cytotoxicity, cellular accumulation and cell cycle modifications of cisplatin and trans-[PtCl2E(iminoether)2] in human and ovarian carcinoma cell lines 40
Antiviral and antitumour properties of a platinum(II) complex with acyclovir 39
Bone Marrow Fibroblasts and Multiple Myeloma Progression. 38
Synthesis and in vitro antitumour activity of platinum acetonimine complexes 37
Method for synthesizing complexes of platinum with iminoethers and their use as antitumoral drugs and nucleotide base modifiers 36
Complessi antitumorali di platino a geometria trans 36
Inhibition of matrix metallo proteinase activity by novel platinum complexes with bisphosphonate analogues 34
null 33
null 33
Platinum complexes with cyclic ligands mimicking iminoether species, synthesis and biological activity 32
Breast Cancer's Microarray Data: Pattern Discovery Using Nonnegative Matrix Factorizations. 31
Pharmacological actions of new platinum-diethyl{(methylsulfinyl)methyl}phosphonate complexes 30
Mechanistic studies on platinum(II) complexes with iminoethers: a trans platinum antitumor agent. 30
null 28
In vitro and in vivo antitumour activity and cellular pharmacological properties of new platinum-iminoether complexes with different configuration at the iminoether ligands 28
Analysis of fibroblast genes selected by NMF to reveal the potential crosstalk between ulcerative colitis and colorectal cancer 28
In vitro effects of ruthenium complex [ImH][trans-RuCl4(DMSO)Im] on angiogenenic propreties of endothelial cells 27
Synthesis and in vitro and in vivo antitumour activity of new platinum-iminoether derivatives with different configuration at the iminoether ligands 27
Complessi di platino a geometria trans: nuove strategie di scoperta e sviluppo di farmaci antitumorali di platino. 27
Colorectal cancer in Crohn's disease evaluated with genes belonging to fibroblasts of the intestinal mucosa selected by NMF 27
The activation of trans geometry in antitumor platinum complexes from iminoether to acetonimine ligands 25
The Bisphosphonate Zoledronic Acid Affects the Angiogenic Phenotype of Bone Marrow Endothelial Cells in Multiple Myeloma Patients 24
Interazione DNA-isomeri del [PtCl2(DACH)] 24
Cytotoxicity and DNA binding mode of new platinum iminoether derivatives with different configuration at the iminoether ligands 23
A new generation of platinum anticancer complexes with trans geometry 22
Screening tests for selecting anticancer metal compounds 21
Rhodium (III) analogues of antitumour-active ruthenium(III) compounds: The crystal structure of [ImH] [trans-RhCl4(Im)2] (Im = imidazole) 21
Platinum (II) complexes containing iminoethers: a trans platinum antitumour agent 20
DNA interaction properties of platinum –iminoether complexes 19
New platinum antitumor complexes with chiral diamines 18
Complessi antitumorali di platino a geometria trans 18
Platinum complexes with imino ethers or cyclic ligands mimicking imino ethers: synthesis, in vitro antitumour activity, and DNA interaction properties 18
Platinum(II) complexes with acyclovir: synthesis and biological activity 17
Iminoethers as carrier ligands: a novel trans-platinum complex possessing in vitro and in vivo antitumor activity 17
Differential processing of antitumour-active and antitumour-inactive trans platinum compounds by SKOV-3 ovarian cancer cells 17
Dna interaction properties of new platinum-iminoether derivatives with different configuration at the iminoether ligands 14
Nami-A: A ruthenium compound active on solid tumour metasteses by altering the interaction between tumour cells and host 13
Complessi antimetastatici di rutenio 13
Platinum Complexes Can Inhibit Matrix Metalloproteinase Activity: Platinum-Diethyl[(methylsulfinyl)methyl]phosphonate Complexes as Inhibitors of Matrix Metalloproteinases 2, 3, 9, and 12 13
In vitro antitumor activity of 2-acetyl pyridine 4n-ethyl thiosemicarbazone and its platinum(II) and palladium(II) complexes 13
Synthesis and antitumour activity of two new trans-[PtCl2(iminoether)2] complexes 12
Cluster of resistance-inducing genes in MCF-7 cells by estrogen, insulin, methotrexate and tamoxifen extracted via NMF 11
A trans-platinum complex showing higher antitumor activity than the cis congeners 11
Totale 4.934
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.519
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.519
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019262 0 0 0 0 0 0 0 0 0 0 122 140
2019/20201.124 240 57 27 90 96 63 112 74 105 70 174 16
2020/2021957 111 80 108 36 123 67 47 51 118 109 74 33
2021/2022555 15 90 4 9 25 23 30 19 28 34 102 176
2022/2023995 149 106 78 75 130 118 8 144 147 9 15 16
2023/2024372 30 50 19 18 60 135 6 33 11 10 0 0
Totale 4.988